常见问题(FAQs)

What dose of an antagonist, agonist, or signaling tool should be used in vitro?

What dose of an antagonist, agonist, or signaling tool should be used in vitro?

   The amount of antagonists, agonists or ssignaling tool required depends on many factors, including targeted accessibility, duration of incubation, and type of cells or assay used. It is best to survey the literature to determine the IC50 value (the concentration of inhibitors when reaching 50% inhibitory effect) EC50 value (the concentration when the drug reaches 50% of the maximum clinical efficacy (which can be inhibition or stimulation)) or Ki value (the concentration of the inhibitor when 50% inhibition effect is measured (obtained by Michaelis equation dynamics calculation)). For an inhibitor, if published Ki or, IC50 values are known, we recommend that you use 5 to 10 times higher than these values to maximally inhibit enzyme or receptor activity. If there are no published values we recommend that you perform dose-response experiments (running appropriate controls) and use Michaelis-Menten kinetics to determine the Ki value.

目录: 常见问题(FAQs)
探索主题: In vitro

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《What dose of an antagonist, agonist, or signaling tool should be used in vitro?》. 阿拉丁知识库,更新于 2022年7月6日。 https://www.aladdin-e.com/zh_cn/faqs/aladdin-in-vitro-en.html
这篇文章对您有帮助吗? Yes No 有 2 人觉得有帮助